JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 15, 2003; DOI: 10.1124/jpet.103.051342


0022-3565/03/3063-973-979$20.00
JPET 306:973-979, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.051342v1
306/3/973    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brabeck, C.
Right arrow Articles by Bürkle, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brabeck, C.
Right arrow Articles by Bürkle, A.

NEUROPHARMACOLOGY

L-Selegiline Potentiates the Cellular Poly(ADP-Ribosyl)ation Response to Ionizing Radiation

Christine Brabeck, Ragen Pfeiffer, Alan Leake, Sascha Beneke, Ralph Meyer, and Alexander Bürkle

Abteilung Tumorvirologie, Deutsches Krebsforschungszentrum, Heidelberg, Germany (C.B., R.P., S.B., R.M., A.B.); and Department of Gerontology, University of Newcastle, Newcastle upon Tyne, UK (R.P., A.L., A.B.)

DNA strand breaks induced by alkylating agents, oxidants, or ionizing radiation trigger the covalent modification of nuclear proteins with poly(ADP-ribose), which is catalyzed for the most part by poly(ADP-ribose) polymerase-1 and plays a role in DNA base-excision repair. Poly(ADP-ribosyl)ation capacity of mononuclear blood cells correlates positively with life span of mammalian species. Here, we show that L-selegiline, an anti-Parkinson drug with neuroprotective activity and life span-extending effect in laboratory animals, can potentiate {gamma}-radiation-induced poly(ADP-ribose) formation in intact cells. COR4 hamster cells were incubated with L-selegiline (50 nM) for various time periods, followed by {gamma}-irradiation (45 Gy). Quantification of cellular poly(ADP-ribose) levels at 10 min after starting the irradiation revealed significant increases (up to 1.8-fold) in cells preincubated with the drug for 8 h to 7 days compared with drug-free irradiated controls. There was no selegiline-induced change in poly(ADP-ribose) levels of unirradiated cells nor in basal or radiation-induced DNA strand breaks, respectively. Surprisingly, poly(ADP-ribose) polymerase-1 protein was down-regulated by L-selegiline treatment. Addition of L-selegiline to purified poly(ADP-ribose) polymerase-1 did not alter enzymatic activity. In conclusion, the results of the present study identify a novel intervention to potentiate the cellular poly(ADP-ribosyl)ation response. We hypothesize that the effect of L-selegiline is due to modulation of accessory proteins regulating poly(ADP-ribose) polymerase-1 activity and that increased cellular poly- (ADP-ribosyl)ation capacity may contribute to the neuroprotective potential and/or life span extension afforded by L-selegiline.


Received March 6, 2003; accepted May 13, 2003.

Address correspondence to: Prof. Alexander Bürkle, Department of Biology, University of Konstanz, Box X911, D-78457 Konstanz, Germany. E-mail: alexander.buerkle{at}uni-konstanz.de




This article has been cited by other articles:


Home page
Stem CellsHome page
G. Saretzki, L. Armstrong, A. Leake, M. Lako, and T. von Zglinicki
Stress Defense in Murine Embryonic Stem Cells Is Superior to That of Various Differentiated Murine Cells
Stem Cells, November 1, 2004; 22(6): 962 - 971.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
T. KURZ, A. LEAKE, T. VON ZGLINICKI, and U. T. BRUNK
Lysosomal Redox-Active Iron Is Important for Oxidative Stress-Induced DNA Damage
Ann. N.Y. Acad. Sci., June 1, 2004; 1019(1): 285 - 288.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.